Chapter 26 Analysis of new drugs (begging to read it!)
In the early morning, Lu Liang got up from bed early in the dormitory.
Today is the weekend and there are no classes in school, so Lu Liang plans to continue going to the library.
Lao Lu, are you ready to go out so early?
Cheng Ming, who was lying on the bed, glanced at Lu Liang drowsily. The social activities organized by the college were in the afternoon, so they were not in a hurry to get up now.
Lu Liang replied: Haven't you heard that the early bird catches the worm?
Lao Lu, you also have to think about it, will the early bird eat the bug?
Well it seems to make sense.
Lu Liang washed himself briefly and then put the computer into his backpack.
Lao Lu, remember to turn off the lights. Cheng Ming said while yawning.
After putting his schoolbag on his back, Lu Liang turned off the lights in the dormitory and hurried out.
There were not many people in the library at the moment, but he still chose a slightly remote place as usual, and then took out the computer from his backpack.
Lu Liang found yesterday's article on the study of the insulin signaling pathway. He was only halfway through the article, and he continued to read on.
This article studies the relationship between the AMPK signaling pathway and the insulin signaling pathway.
The AMPK signaling pathway is a relatively important signaling pathway among many signaling pathways, and there are countless studies on the AMPK signaling pathway.
AMPK can increase the basal phosphorylation level of AKT on Ser473 of the insulin signaling pathway.
In a sense, this can be regarded as improving insulin resistance to a certain extent, Lu Liang thought about it.
Lu Liang briefly checked the AMPK signaling pathway.
He found that most research on the AMPK signaling pathway focused on lipid metabolism.
The biggest role of the AMPK signaling pathway is to inhibit the synthesis of fat and promote the decomposition of fat. It is the deadly enemy of fat.
Is it lipid metabolism again? It seems that obesity is really an unavoidable hurdle in terms of insulin resistance.
However, research shows that obesity is an important factor in insulin resistance.
It can be considered related.
Lu Liang continued to investigate along this line of thought.
After looking through countless documents, Lu Liang finally finished reading the content related to insulin resistance. After roughly understanding the relationship between type 2 diabetes and insulin resistance, the literature search was almost over.
Lu Liang looked up from the screen, stretched hard, and then glanced at the time.
What surprised Lu Liang was that it was already past eleven o'clock, and he had been watching for four full hours.
Let's continue after eating, Lu Liang thought to himself.
He didn't want to miss the meal in the cafeteria like yesterday and had to go to the snack street to buy pancakes and fruits.
Lu Liang simply packed up his things and left the library.
As soon as he left the library, Lu Liang felt a heat wave coming towards him. The weather in September was already sultry, and it was already noon, so the sun was extremely scorching, causing the air to become a little distorted.
Slogans came from the playground not far away, and the first-year students have now begun military training.
Lu Liang came to the canteen and ordered two vegetarian dishes at the window.
One is spicy cabbage and the other is fried pork with chili.
It's just that the chili fried pork is full of chili peppers and no meat.
Holding the tableware, Lu Liang found a seat in the canteen and sat down, and began to think while eating.
At present, he has seen almost everything about type 2 diabetes and insulin resistance.
Then the next most important thing comes.
That’s analyzing liraglutide!
Lu Liang glanced at the source points in the system again.
With the sale of Bai Shuke, the source point soared from 0.72 to 1.3, and then slowly stopped.
Then coupled with his two days of study, he has collected a total of 1.4 source points so far.
These sources are enough to support him in analyzing new drugs for type 2 diabetes.
Thinking of this, Lu Liangliang couldn't help but feel excited. He wanted to know what kind of medicine he could analyze this time.
After hurriedly finishing the food on the plate, Lu Liang took a bottle of Coke and walked towards the library.
After returning to his seat, Lu Liang turned on the computer again. He couldn't wait to search for relevant literature on liraglutide on CNKI.
There are a lot of relevant literature on liraglutide on CNKI, but most of them are research on drug efficacy.
Lu Liang added keywords such as process route, and soon, related drug synthesis research on liraglutide jumped out of the screen.
After seeing the drug synthesis route of liraglutide, Lu Liang once again saw a familiar interface in front of him.
[Level: lv2]
[Analysis target: Liraglutide]
[A human glucagon-like peptide-1 analogue can promote insulin secretion, inhibit glucagon secretion, and improve the body's insulin resistance. It is a therapeutic drug for type 2 diabetes. 】
[Source points required for analysis: 0.7]
[Existing source point: 1.4]
[Analysis: A new drug for type 2 diabetes can be obtained randomly. 】
【Do you want to analyze? 】
When seeing this interface, Lu Liang suddenly felt a little surprised.
Previously, one source point was used to analyze Gleevec, but this time only 0.7 source points were needed to analyze liraglutide.
There are 0.3 fewer source points than before.
Could it be that the difficulty of drug analysis is different, so the required source points are also different?
Lu Liang simply speculated that the type 2 diabetes treated by liraglutide is a chronic systemic disease, but Gleevec treats cancer, and the technical threshold of the drug is different.
Thinking of this, Lu Liang was suddenly curious. He wanted to know how many source points were needed to analyze drugs with different technical difficulties.
Lu Liang quickly searched the Internet for the synthesis route of cold medicine.
[Level: lv2]
[Analysis object: aspirin]
[Common cold medicine, also known as acetylsalicylic acid, is mainly used to reduce fever in colds, flu and other febrile diseases. 】
[Source points required for analysis: 0.08]
[Existing source point: 1.4]
[Analysis: A new type of cold medicine can be obtained randomly. 】
【Do you want to analyze? 】
Sure enough, the analysis of cold medicine aspirin only requires 0.08 source points, which is a full 0.62 fewer than liraglutide.
Lu Liang became even more curious because he suddenly remembered the most expensive drug he had ever seen in his previous life.
1.2 million injections of the anti-cancer miracle drug - Aquilenza Injection.
It is said that this drug can directly eliminate cancer cells with one injection.
I don’t know how many source points are needed for the analysis of this drug?
With a curious attitude, Lu Liang began to search for Akilonsai Injection on the Internet.
But after searching for a while, Lu Liang did not find any reports about Akilonsai Injection on the Internet.
Could it be that this kind of medicine has not yet appeared in this world?
Lu Liang thought for a moment. He didn't know whether drugs that had not yet been developed could be analyzed by the system.
He could only close his eyes and recite the words Akiron Race silently in his mind.
The result shocked Lu Liang even more. After he read silently for a few seconds, the interface appeared in front of him again.
[Level: lv2]
[Analysis object: Akilensai injection (CAR-T cell therapy)]
[This is a type of cell therapy that needs to be customized for different patients. It extracts the patient's T cells, transforms and strengthens the T cells, and then infuses them back into the patient's body to achieve the purpose of treatment. 】
[It has been detected that there is currently no Aquilenza injection on the market, and the process technology of Akilenza can be directly provided. 】
[Source points required for analysis: 99]
[Existing source point: 1.4]
[There are not enough source points to analyze. 】
After seeing the information about Akilun Sai, Lu Liang's eyes suddenly widened.
99 source points?
System, are you trying to kill me?